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In their retrospective review, Li et al1 have described 
the medium-term clinical and radiological results 
of Zweymüller-Plus total hip arthroplasty (THA) 
in 185 Chinese patients (207 hips). The articulation 
size was 28 mm, with conventional ultra-high-
molecular-weight polyethylene (UHMWPE) over 
the acetabular side and third-generation alumina 
ceramics on the femoral side. Due to the number of 
patients lost to follow-up and other reasons, the final 
numbers of patients and hips available for analysis 
were 156 and 175, respectively. The mean duration 
of follow-up was 14.1 years. The series comprised 
both primary and revision THA cases. One should 
be aware of the complexity of the latter and that 
their results may not be directly comparable with 
the former. All the surgeries were performed before 
the year 2000, when UHMWPE was still widely used 
around the world.
 The authors reported satisfactory clinical 
outcomes.1 Two out of 175 hips were revised, making 
the true revision rate of 1.1%, excluding those who 
were lost to follow-up. Two hips were found to have 
excessive polyethylene wear, although the authors 
did not define ‘excessive’. Osteolysis or radiolucent 
lines were detected in 4% of the femora and 1.7% 
of the acetabula. There are three major limitations 
in this study in terms of measuring polyethylene 
wear and survival analysis. First, the method used 
to measure UHMWPE liner wear in the study was 
imprecise, as admitted by the authors. The modern 
standard of measuring wear requires the use of 
computer software based on the concentricity 
of the hip ball and liner.2 Second, the authors 
mentioned that their desired acetabular component 
position was 45° ± 10° of abduction and 15° ± 10° of 
anteversion. However, they did not reveal the mean 
postoperative angles, although malpositioning of 
the acetabular component is a known risk factor of 
excessive polyethylene wear. Third, the high number 
of patients lost to follow-up (13.5%) might have 
underestimated the revision rate and overestimated 
the overall survival of the prostheses.
 Chiu et al3 reported the results of THA in 
patients below 40 years of age and found UHMWPE 
wear and osteolysis in 56% of the hips with 28-mm 
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metal on UHMWPE articulation. Of note, UHMWPE 
has inferior wear resistance and therefore generates 
wear particles that induce osteolysis and cause 
aseptic loosening in THA.4-8 Highly cross-linked 
polyethylene (HXLPE) was introduced for clinical 
use in THA in 1998, aiming to reduce wear and 
improve its longevity.9 In-vitro9-13 and in-vivo11,14-17 
studies suggested that HXLPE had superior wear 
resistance and caused less osteolysis. Li et al18 
studied the linear penetration of HXLPE in young 
Chinese patients with THA and found the wear rate 
was 0.025 mm/year.
 In their meta-analysis, Kurtz et al19 also 
investigated the incidence of osteolysis in patients 
with UHMWPE liners and HXLPE liners by 
calculating odds ratios from individual cohort (n=8) 
and randomised controlled trial (n=1) studies with 
a minimum of 5-year follow-up. The combined and 
the pooled odds ratio was estimated to be 0.131 
(95% confidence interval [CI], 0.064-0.268) using 
a random-effects model which indicates that the 
incidence of osteolysis was 87% lower in patients 
with HXLPE liners compared with patients with 
conventional polyethylene liners.19 Hanna et al20 
followed a cohort of 160 patients (179 THAs) 
between the ages of 45 and 65 years who received 
liners made of either UHMWPE (n=89) or HXLPE 
(n=88). The cumulative implant survival, with 
revision for polyethylene wear or osteolysis as 
an endpoint, was 86% (95% CI, 78%-94%) in the 
UHMWPE group and 100% in the HXLPE group at 
13 years postoperatively.20 Data from a United States 
registry also suggested that the revision rates for 
THAs utilising HXLPE are lower than that for non-
crosslinked UHMWPE. Paxton et al21 found that at 
7 years of follow-up, the cumulative incidence of 
revision was 5.4% (95% CI, 4.4%-6.7%) for metal-on-
UHMWPE compared with 2.8% (95% CI, 2.6%-3.2%) 
for metal-on-HXLPE.
 In their study, Li et al1 did not explain in detail 
why their cohort showed a much lower incidence 
of excessive polyethylene wear or aseptic loosening 
compared with the literature. One possible 
explanation could be the age of the studied patients: 
more than half of their patients were older than 60 
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years. It is well known that ‘wear is a function of use, 
not time’. Elderly patients are generally less physically 
active, and this results in less wear.
 The study by Li et al1 demonstrated good 
clinical and radiological outcomes with THA with 
ceramic on UHMWPE articulation in a Chinese 
population. The data, however, are of little clinical 
significance in today’s practice as most of the THAs 
utilised HXLPE liner; UHMWPE liners are obsolete.
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